Skip to main content
Caplight Logo









Noa Therapeutics

Noa Therapeutics

Private
TorontoHealthcare & Life Scienceshttps://noatherapeutics.com/

Last Round

Pre Seed

Mar 7, 2024

Total Funding Raised

$1.64M

Company Overview

Noa Therapeutics is a biotechnology company that develops novel trimodal small molecule therapeutics to address complex inflammatory barrier diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

small-molecule therapeuticsdrug discoverycomputational biologyin silico drug discoveryinflammatory diseasesaryl hydrocarbon receptorAhRatopic dermatitismultimodal compoundsbiotech startuppreclinical biotechdrug discovery platformAI-augmented drug discoverybiotechpharma tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Noa Therapeutics Comparables

Compare Noa Therapeutics with similar companies based on industry and business-model similarity.

Noa Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Athos Therapeutics
81%
Equillium Inc.
71%
Edesa Biotech Inc
69%

Noa Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedMar 7, 2024

Key People

Founding team and executive leadership

Carla Spina

CEO & President

Executive Team

Noa Therapeutics Investors

Notable investors and investment history

Noa Therapeutics investors
InvestorRounds
Angel One NetworkPre Seed
Golden Triangle Angel NetworkPre Seed
Archangel NetworkPre Seed
NorthSpring Capital PartnersPre Seed
University of CalgaryPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 5, 2026

    Monthly visitors grew 513% MoM to 1.8K.

  • May 12, 2025

    Grew 50% QoQ from 8 to 12 employees.

Noa Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Noa Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Noa Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersToronto
Employee Range10
Year Founded2022
Last FundingMar 7, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?